人体基因编辑技术在医学领域的应用亟待规范  

The application of human genetic technology in the medical field urgently needs standardization

作　　者：唐子艳 刘志成 吴永超[2] Tang Ziyan;Liu Zhicheng;Wu Yongchao(School of Law,Humanities and Social Sciences,Wuhan University of Technology,Wuhan 430070,China;Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology,Wuhan 430022,China)

机构地区：[1]武汉理工大学法学与人文社会学院,武汉430070 [2]华中科技大学同济医学院附属协和医院,武汉430022

出　　处：《中华医学杂志》2024年第4期247-250,共4页National Medical Journal of China

基　　金：国家社会科学基金项目

摘　　要：人体基因编辑技术是生物技术发展的热点和重点,但随之也引起了技术风险、基因生物安全、人类社会伦理尊严和应用合法性的争议,引发了人们对应用该技术的担忧。国际上普遍禁止以生殖为目的基因编辑,各国依据本国情况建立法律规范体系来规范基因编辑技术的应用。我国应当建立基因编辑技术安全风险准入制度,保障国家生物安全,建立健全科研伦理规范体系,完善立法规范化建设,为研究和应用基因编辑技术提供法治保障。Human gene editing technology is a hot spot and focus in the development of biotechnology,but it has also caused controversies over technical risks,genetic biosecurity,ethical dignity of human society and the legality of application,causing people to worry about the application of this technology.Gene editing for reproductive purposes is generally prohibited internationally,and countries have established legal regulatory systems to regulate the application of gene editing technology according to their own conditions.China shall establish a security risk access system for gene editing technology,ensure national biosecurity,establish and improve the system of ethical norms for scientific research,improve the construction of legislative standardization,and provide legal guarantees for the research and application of gene editing technology.

关 键 词：基因编辑 制度 法律规制 责任 

分 类 号：R318[医药卫生—生物医学工程]